Abstract: Provided is a cell product for treating myocarditis, comprising a SSEA-3-positive pluripotent stem cell derived from a mesenchymal tissue in a living body or a SSEA-3-positive pluripotent stem cell derived from a cultured mesenchymal cell.

Abstract: An operation method of a transmitter in a communication system may comprise: configuring a first reference signal region for transmission of a first reference signal in the delay-Doppler domain; arranging the first reference signal having a sequence form in a specific region within the first reference signal region; transforming a delay-Doppler domain signal including the first reference signal into a time domain signal; and transmitting the time domain signal to a receiver.

Abstract: Provided is a system for predicting disease based on biosignal data and medical knowledge base convergence. The system includes a first system unit configured to receive, from a user terminal, biosignal data collected from at least one sensor for sensing a biosignal, and calculate a disease score from the biosignal data based on a pre-trained prediction model, a second system unit configured to provide medical knowledge data for the first system unit, analyze a query input from the user terminal to provide a corresponding response, and augment the medical knowledge data based on the query and response; and a unified distributed repository that includes a database for enqueuing the biosignal data, a manager database for storing additional information of a user, and a medical knowledge base for storing predetermined medical knowledge data.

Abstract: The present disclosure features CX3CR1 hemizygous and/or homozygous defective cells and methods of using such cells for the treatment of a metabolic or neurological disorder. The disclosed methods include methods for making and modifying CX3CR1 hemizygous and/or homozygous defective cells, such as hematopoietic stem progenitor cells. Other disclosed methods include methods of treating a subject having or suspected of having a metabolic or neurological disease comprising administering to the subject a composition comprising a hemizygous and/or homozygous defective CX3CR1 cell. The CX3CR1 hemizygous and/or homozygous defective cell may be modified to have a nucleic acid molecule encoding a therapeutic polypeptide or polynucleotide.

Abstract: The present invention provides a measuring device which includes: a first container and a second container that are arranged adjacent to each other; and a partition wall provided between the first and second containers, the partition wall having a through hole(s) for forming a lipid bilayer(s). In this measuring device, a gas flow path(s) having a hydrophobic surface is/are formed in at least one of the first and second containers; the gas flow path(s) has/have an inlet and an outlet; the inlet and the outlet each communicate with the exterior of the measuring device; the gas flow path(s) open(s) into the container in which it/they is/are formed; and a gas flowing in the gas flow path(s) contacts the droplet filled in the container.

Abstract: The present invention relates to a method and an apparatus for interlayer prediction, and the method for interlayer prediction, according to the present invention, comprises the steps of: deciding whether to apply an interlayer prediction to an enhancement layer; and performing a prediction on a current block of the enhancement layer based on reference information that is generalized and generated from a reference picture, which is decoded, of a reference layer, when the interlayer prediction is applied, wherein the reference layer information can be encoding information of a reference block, which corresponds to a current block of the enhancement layer, from the reference layer, and residual information.

Abstract: The present invention relates to a multi-path converter, which adds a current transfer path using a capacitor to a current transfer path using an inductor to supply a current that is output to an output end (load) to a plurality of parallel paths, thereby reducing a total RMS current flowing through the inductor, and a control method therefor.

Abstract: The present invention provides a construction method for automatic sleep staging and use thereof.

Abstract: Disclosed herein are a container orchestration apparatus in an environment of multiple geographically distributed clouds and a method using the same. The container orchestration method includes receiving, by the container orchestration apparatus, a service request from a device using service; and dynamically deploying, by the container orchestration apparatus, a service node and a service instance for processing the service request based on auto-scheduling of a container orchestration cluster based on the environment of multiple geographically distributed clouds.

Abstract: Disclosed herein is an interaction monitoring system, comprising an environment collection module, interaction monitoring module, interaction segmentation module, and display module. The environment collection module detects surrounding environment and generates a data stream. The interaction monitoring module generates a feature data stream by extracting feature value of the data stream. The interaction segmentation module determines a target situation, which indicates a user's state or condition, from the feature data stream and generates a target image or video stream, which indicates the target situation. The display module displays the target image. Other embodiments are described and shown.

Abstract: A phase change material, a phase change memory cell, and a preparation method thereof. The phase change material comprises elements tantalum, antimony and tellurium, the phase change material having a chemical formula of TaxSbyTez, wherein x, y, and z represent atomic ratios of the elements respectively; and 1?x?25, 0.5?y:z?3, and x+y+z=100. The phase change thin film material TaxSbyTez has a high phase change speed, outstanding thermal stability, strong data retention capability, a long cycle life, and a high yield. Ta5.7Sb37.7Te56.6 has ten-year data retention capability at 165° C.; and applying same in a device cell of a phase change memory achieves an operating speed of 6 ns and endurance of more than 1 million write-erase cycles. The crystal grains of the phase change material TaxSbyTez of the present disclosure are small, and after annealing treatment at 400° C. for 30 minutes, the grain size is still smaller than 30 nm.

Abstract: Epitaxial growth of materials, and related systems and articles, are generally described.

Abstract: The present disclosure relates to a method for recognizing facial expressions based on adversarial elimination. First, a facial expression recognition network is built based on a deep convolutional neural network. On a natural facial expression data set, the facial expression recognition network is trained through a loss function to make facial expression features easier to distinguish. Then some key features of input images are actively eliminated by using an improved confrontation elimination method to generate a new data set to train new networks with different weight distributions and feature extraction capabilities, forcing the network to perform expression classification discrimination based on more features, which reduces the influence of interference factors such as occlusion on the network recognition accuracy rate, and improving the robustness of the facial expression recognition network.

Abstract: The present specification discloses a membrane reactor comprising a reaction region; a permeate region; and a composite membrane disposed at a boundary of the reaction region and the permeate region, wherein the reaction region comprises a bed filled with a catalyst for dehydrogenation reaction, wherein the composite membrane comprises a support layer including a metal with a body-centered-cubic (BCC) crystal structure, and a catalyst layer including a palladium (Pd) or a palladium alloy formed onto the support layer, wherein ammonia (NH3) is supplied to the reaction region, the ammonia is converted into hydrogen (H2) by the dehydrogenation reaction in the presence of the catalyst for dehydrogenation reaction, and the hydrogen permeates the composite membrane and is emitted from the membrane reactor through the permeate region.

Abstract: This invention discloses method for preparing a non-radioactive standard ?-CFT. Using cocaine hydrochloride as the starting material, and after a series of hydrolysis, dehydration, esterification and bonding reactions, a non-radioactive standard (2?-Carbomethoxy-3?-(4-fluoropenyl) tropane) is prepared. Furthermore, this preparation method has fewer steps, is easy to operate, and the purity of the product is as high as 97.97%. Therefore, the method for preparing a non-radioactive standard ?-CFT can promote the development of positron imaging in the diagnosis of Parkinson's disease.

Abstract: Provided is a fluid viscosity measuring device including a support structure having an opening part, the opening part penetrating the support structure in a first direction, a driving resonator fixed to the support structure and extending to overlap the opening part, and a detection resonator fixed to the support structure and extending parallel to the driving resonator, the detection resonator being spaced apart from the driving resonator in the first direction. The driving resonator includes a first piezoelectric body. The detection resonator includes a second piezoelectric body. The first piezoelectric body and the second piezoelectric body have the same shape.

Abstract: Provided are a storage device using a neural network and an operating method of the storage device for automatic redistribution of information and variable storage capacity based on accuracy-storage capacity tradeoff that may learn input information using the neural network and may store the learned information. The neural network may include a plurality of input neurons and a plurality of output neurons; at least one stable synapse configured to connect at least one of the input neurons and at least one of the output neurons, respectively; and at least one flexible synapse configured to connect at least one remaining of the input neurons and at least one remaining of the output neurons, respectively.

Abstract: A method for purification of a styrene-containing feedstock includes steps of introducing the styrene-containing feedstock into the middle of an extractive distillation column, and a solvent for the extractive distillation into the upper part of the column; discharging a raffinate oil from the top of the column, and a rich solvent rich in styrene from the bottom of the column. The rich solvent is then introduced into the middle of the solvent recovery column for vacuum distillation to obtain a crude styrene from the top of the solvent recovery column, and a lean solvent is discharged from the bottom of the solvent recovery column and recycled to the upper part of the extractive distillation column. A portion of the rich solvent is sent to a solvent purification zone for a liquid-liquid extraction using water to obtain a mixture of a styrene polymer and styrene.

Abstract: Provided are use of a saponin compound of formula (I) or (II), or a pharmaceutically acceptable salt, prodrug or solvate thereof, in the manufacture of a medicament targeting PD-1. The medicament targeting PD-1 is one which treats a disease by inhibiting PD-1 from binding to a ligand thereof. The disease may be a tumor, an infection caused by a bacterium, a virus or a fungus, or an inflammatory disease.

Abstract: Prosthetic devices and, more particularly, modular myoelectric prosthesis components and related methods, are described. In one embodiment, a hand for a prosthetic limb may comprise a rotor-motor; a transmission, comprising a differential roller screw; a linkage coupled to the transmission; and at least one finger coupled to the linkage. In one embodiment, a component part of a wrist of a prosthetic limb may comprise an exterior-rotor motor, a planetary gear transmission, a clutch, and a cycloid transmission. In one embodiment, an elbow for a prosthetic limb may comprise an exterior-rotor motor, and a transmission comprising a planetary gear transmission, a non-backdrivable clutch, and a screw.